Essays about: "safety in pharmaceutical industry"

Showing result 1 - 5 of 12 essays containing the words safety in pharmaceutical industry.

  1. 1. Optimization of two high-performance size-exclusion chromatography methods with diode-array detection for protein quantification and purity assessment

    University essay from Lunds universitet/Centrum för analys och syntes

    Author : Camilla Lane; [2023]
    Keywords : Method qualification; Protein concentration; Protein Purity; High Performance Size exclusion chromatography; Quality control; Analytical chemistry; Biology and Life Sciences;

    Abstract : Background: There is a need to develop methods of determining concentration and purity for two new affinity ligands, protein T and protein H, in order to ensure the quality of an industrial production of said proteins. Aims: To develop a High Performance Size Exclusion Chromatography, HPSEC, method to determine concentration and purity of protein T and to improve an existing HPSEC method for concentration and purity determination of protein H that show selectivity, display linearity between peak area and injection amount and give repeatable results. READ MORE

  2. 2. Influence of Peristaltic Pump Tubes on Protein Particles Formation for Lipase Enzyme Therapeutic Protein

    University essay from Lunds universitet/Livsmedelsteknik och nutrition (master)

    Author : Salah Elden Omer; [2023]
    Keywords : Dynamic Image analysis; Protein aggregation; Peristaltic pump tubing; Particle characterization; PVC tubing; Silicone tubing; Surfactant; QICPIC; Pharmaceutical technology; Biology and Life Sciences;

    Abstract : Introduction: In Bio-pharmaceutical production, peristaltic pump tubing is considered one of the factors that influence protein aggregation. Background: Protein particles present challenges for the control and analysis of various manufacturing processes in the biopharmaceutical industry for their significant effects on safety and quality. READ MORE

  3. 3. Sustainability Report in the context of pandemic from legitimacy theory and stakeholder theory perspective - A case study of Nordic Region Pharmaceutical companies

    University essay from Lunds universitet/Företagsekonomiska institutionen

    Author : Oloruntobiloba Idowu-Aire; Nanxi Li; [2022]
    Keywords : Sustainability Reporting; pharmaceutical industry; nonfinancial information disclosure; stakeholder theory; legitimacy theory; Business and Economics;

    Abstract : Purpose: This study aims to determine how a company uses sustainability reporting to engage its stakeholders, with a view toward analysing legitimacy theory and stakeholder theory. Sustainability disclosure is a key source for determining whether a stakeholder will keep a relationship with a company. READ MORE

  4. 4. Effects of pharmaceutical excipients on the chemical stability of therapeutic proteins in a parenteral formulation

    University essay from Lunds universitet/Livsmedelsteknik och nutrition (master)

    Author : Emmanuel Gulangayan Deniola; [2022]
    Keywords : Chemical stability; protein degradation; GA-Z; somatropin; pharmaceutical excipients; liquid chromatography; pharmaceutical technology; Chemistry;

    Abstract : Proteins and peptides are widely used for the prevention, management, and cure of various illnesses. This vast therapeutic potential represents a significant portion of the pharmaceutical industry in the form of vaccines, antibodies, enzymes, and other protein-based therapeutics. READ MORE

  5. 5. Digitally Enabled, Wearable Remote Patient Monitoring of Clinical Trials to Assess Patient Reported Outcomes-A Systematic Review : Shifting Paradigm from Site-Centric to Patient Centric Health Care

    University essay from Högskolan i Halmstad/Akademin för hälsa och välfärd

    Author : Harsimran Kaur; [2021]
    Keywords : Clinical Trials; Digitalisation; Remote Patient Monitoring; Wearable Medical Devices.;

    Abstract : Summary: Although the digital revolution has transformed many niches of human activity, healthcare sector and pharmaceutical drug development has been relatively slow in embracing emerging technologies to optimize health efficacy, especially in Nordic Countries. The topic is of more importance now owing to the present scenario of the corona virus (COVID-19)outbreak, which has caused unparalleled disruption in the conduct of clinical trials and presented challenges as well as opportunities for clinical trialists and data analysts. READ MORE